Trade Vir Biotechnology VIR

VirBiotechnology live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Apr 26, 19:43

Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?

Vir Biotechnology Inc
Webhose 2026 Apr 22, 14:27

Vir Biotechnology (VIR) Posts 80.98% Year-To-Date Growth

Vir Biotechnology Inc
Webhose 2026 Apr 21, 18:19

10 Best Small-Cap Biotech Stocks According to Hedge Funds

Vir Biotechnology Inc
Webhose 2026 Apr 21, 13:09

Vir Biotechnology (VIR) Is Up 19.1% After Astellas Cancer Pact Closes With $315M Inflows

Vir Biotechnology Inc
Webhose 2026 Apr 20, 14:47

Can Vir Biotechnology (VIR)'s Masked T-Cell Technology Crack the Hardest-to-Treat Prostate Cancer?

Vir Biotechnology Inc
Webhose 2026 Apr 20, 13:58

Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year High - Here's Why - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Apr 20, 00:11

Is Vir Biotechnology (VIR) One of the Best Low Priced Biotech Stocks to Invest In?

Vir Biotechnology Inc
Webhose 2026 Apr 16, 22:15

Vir Biotechnology (VIR) Valuation After Astellas Partnership And New VIR 5500 Trial Milestone

Vir Biotechnology Inc
Webhose 2026 Apr 16, 12:05

Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer | Morningstar

Vir Biotechnology Inc
Webhose 2026 Apr 13, 14:05

Phase 1 trial designed to assess the safety, pharmacokinetic

Vir Biotechnology Inc
Webhose 2026 Apr 13, 07:45

Brokerages Set Vir Biotechnology, Inc. (NASDAQ:VIR) PT at $20.44

Vir Biotechnology Inc
Webhose 2026 Apr 12, 09:21

Should Vir's CMO Exit and Astellas Funding Boost Reshape How Investors View Its R&D Strategy (VIR)?

Vir Biotechnology Inc
Webhose 2026 Apr 10, 13:51

Vir Biotechnology (VIR) Leading with Its BiTEs Therapy

Vir Biotechnology Inc
Webhose 2026 Apr 09, 07:02

Aberdeen Group plc Sells 135,688 Shares of Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc
Webhose 2026 Apr 08, 08:13

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages

Vir Biotechnology Inc
Webhose 2026 Apr 07, 22:10

Vir Biotechnology (NASDAQ:VIR) CEO Backer Marianne De Sells 72,559 Shares

Vir Biotechnology Inc
Webhose 2026 Apr 04, 20:24

Is Vir Biotechnology's (VIR) Insider Selling After Its Capital Raise Reframing the Investment Narrative?

Vir Biotechnology Inc
Webhose 2026 Apr 02, 16:57

Vir Biotechnology (NASDAQ:VIR) Director Sells $199,540.00 in Stock

Vir Biotechnology Inc

VirBiotechnology News

Ghko B 2026 Apr 27, 16:01

ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?

crypto
Ghko B 2026 Apr 27, 16:01

Tech Giant Stock Analysis: How Microsoft (MSFT) Will Boost the AI Industry in 2026?

stocks
Ghko B 2026 Apr 27, 16:01

Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?

stocks
Frances Wang 2026 Apr 26, 16:01

Hang Seng Index drops below 26,000 points: What’s happening with the Hong Kong stock market?

indices
Ghko B 2026 Apr 26, 16:01

How to Start Buying Bitcoin in South Africa in 2026: Easy Ways to Invest in BTC for Beginners in ZA

crypto
Ava Grace 2026 Apr 24, 00:00

Oil Market Paradox: Geopolitical Tensions vs. Stable Prices

Ava Grace 2026 Apr 24, 00:00

US Midterm Elections: Energy Sector Outlook and Investment Implications

Ghko B 2026 Apr 23, 16:01

Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

crypto
Ghko B 2026 Apr 23, 16:01

5 best gold trading apps for 2026: What is the best platform to buy gold in South Africa?

cfd trading commodity
Ghko B 2026 Apr 22, 16:01

O4X.F stock is trending: What’s happening with Karnell Group AB (publ)?

stocks cfd trading

Latest news

Show more
Ghko B 2026 Apr 27, 16:01

Egypt Gold Price Update: How Much Does 21K Gold Cost Per Gram Right Now?

Commodities
Ghko B 2026 Apr 27, 16:01

Gold Price Today, April 28: XAUUSD Hits $4,702 as Safe-Haven Demand Remains Strong Amid Geopolitical Tensions

gold price today
Ghko B 2026 Apr 27, 16:01

South Africa Exchange Control Revamp 2026: Boosting GDP Growth with Billions in New Investment

Ghko B 2026 Apr 26, 16:01

UAE GDP Set for 5.6% Growth in 2026: Non-Oil Growth Continues, Financial Services and Global Trade Accelerate

Ghko B 2026 Apr 26, 16:01

Gold Price Today, April 27: Gold Spot Price XAUUSD Faces Key Resistance Near $4,730

gold price today
Ava Grace 2026 Apr 24, 00:00

Fed Leadership Uncertainty: Powell's Potential Continuation and Political Hurdles

Emma Rose 2026 Apr 24, 00:00

Gerrymandering Backfires: Republicans Fear Election Losses as Districts Are Redrawn

Sophia Claire 2026 Apr 24, 00:00

Fed Nomination Stalemate: Republican Opposition Halts Warsh's Senate Confirmation

Info

Spread

0.07

Spread (%)

0.6829 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1715530496

Shares Outstanding

161234058

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.16

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Julian Parker 2026 Apr 27, 16:03

How to Open a Brokerage Account: A Step-by-Step Guide for New Traders and Investors

Julian Parker 2026 Apr 27, 16:02

Pre-Market Trading Explained: How It Works, Key Risks, Strategies, and What Traders Should Know

Julian Parker 2026 Apr 27, 16:01

What Are Stock Buybacks and How Do They Work?

Trustpilot